
NYSEHealthcareMedical - Devices
Latest quote
$24.30
+$0.21 · +0.87%
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
Latest quote
$24.30
+$0.21 · +0.87%
After-hours
$24.30
$0.00 · 0.00%
Oct 8, 4:00 PM ET
Regular session · ET · Market data may be delayed.
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
Day range
Current $24.30
52-week range
Current $24.30
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
92
Deep Value
Sentiment
59
Mixed
Risk
30
Moderate Risk
Momentum
40
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
Day range
Current $24.30
52-week range
Current $24.30
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (EUR) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.83B EUR | 18.02B EUR | 18.17B EUR | 17.83B EUR | 17.16B EUR |
| Cost of goods sold | 9.78B EUR | 10.25B EUR | 10.72B EUR | 10.63B EUR | 9.99B EUR |
| Gross profit | 8.06B EUR | 7.77B EUR | 7.45B EUR | 7.19B EUR | 7.17B EUR |
| Research and development | 1.7B EUR | 1.75B EUR | 1.89B EUR | 2.09B EUR | 1.81B EUR |
| Selling, general, and administrative | 4.97B EUR | 5.07B EUR | 5.13B EUR | 5.29B EUR | 4.86B EUR |
| Operating expenses | 6.63B EUR | 7.24B EUR | 7.56B EUR | 8.72B EUR | 6.62B EUR |
| Interest income | 108.54M EUR | 79M EUR | 46M EUR | 25M EUR | 18M EUR |
| Interest expense | 332.34M EUR | 337M EUR | 306M EUR | 244M EUR | 164M EUR |
| Depreciation and amortization | 1.13B EUR | 1.39B EUR | 1.26B EUR | 1.6B EUR | 1.32B EUR |
| Operating income | 1.42B EUR | 529M EUR | −115M EUR | −1.53B EUR | 553M EUR |
| Net income | 895M EUR | −702M EUR | −466M EUR | −1.61B EUR | 3.32B EUR |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Cash distributions grouped by calendar year; partial years are marked.
$0.9673
2025 complete year+20.9% since 2020
2026 partial: $0.99
$0.80
2,020
$1.0331
2,021
$0.9641
2,022
$0.9154
2,024
$0.9673
2,025
$0.99
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | May 13, 2026 | $0.99Annual | May 13, 2026 | Jun 3, 2026 |
Dividend | May 13, 2025 | $0.9673Annual | May 13, 2025 | Jun 6, 2025 |
Dividend | May 9, 2024 | $0.9465Annual | May 10, 2024 | May 16, 2024 |
Dividend | May 12, 2022 | $0.819Annual | May 13, 2022 | Jun 8, 2022 |
Dividend | May 10, 2021 | $1.0331Annual | May 11, 2021 | Jun 9, 2021 |
Dividend | May 5, 2020 | $0.93Annual | Jul 1, 2020 | Jun 4, 2020 |
Ex-dividend May 13, 2026
$0.99
Annual
Record May 13, 2026 · Payment Jun 3, 2026
Ex-dividend May 13, 2025
$0.9673
Annual
Record May 13, 2025 · Payment Jun 6, 2025
Ex-dividend May 9, 2024
$0.9465
Annual
Record May 10, 2024 · Payment May 16, 2024
Ex-dividend May 12, 2022
$0.819
Annual
Record May 13, 2022 · Payment Jun 8, 2022
Ex-dividend May 10, 2021
$1.0331
Annual
Record May 11, 2021 · Payment Jun 9, 2021
Ex-dividend May 5, 2020
$0.93
Annual
Record Jul 1, 2020 · Payment Jun 4, 2020
Funds reporting this stock among their holdings, ordered by reported position size.
Dimensional - International Value ETFDFIV23.98M0.11%21.39B USD0.27%$55.28+0.13%
Dimensional - International Core Equity 2 ETFDFIC9.55M0.06%15.01B USD0.22%$37.29-0.13%
Brandes International ETFBINV8.46M1.62%524.95M USD0.70%$43.10+0.15%
Dimensional - International Core Equity Market ETFDFAI7.5M0.04%17.78B USD0.18%$41.07-0.19%
Avantis International Equity ETFAVDE6.92M0.04%19.02B USD0.23%$89.28-0.22%
Dimensional World ex U.S. Core Equity 2 ETFDFAX4.04M0.03%12.37B USD0.28%$36.80-0.76%
ActivePassive International Equity ETFAPIE3.06M0.27%1.17B USD0.45%$38.31-0.70%
CresAlta Global Dividend ETFCVGD2.84M2.12%135.38M USD0.50%$25.19480.00%
Dimensional - International Value ETFDFIV
Dimensional - International Core Equity 2 ETFDFIC
Brandes International ETFBINV
Dimensional - International Core Equity Market ETFDFAI
Avantis International Equity ETFAVDE
Dimensional World ex U.S. Core Equity 2 ETFDFAX
ActivePassive International Equity ETFAPIE
CresAlta Global Dividend ETFCVGDAI-generated and delayed market data for informational and educational purposes only. Not investment advice.